Status:

COMPLETED

Unicentric Retrospective Analysis of a Cohort of 602 Young Adult and Adolescent Patients (AJA), Aged 15 to 30 Years, With Haematological Malignancies, and Managed Between 2000 and 2016

Lead Sponsor:

Institut Paoli-Calmettes

Conditions:

Malignant Haemopathies

Acute Leukemia

Eligibility:

All Genders

15-30 years

Brief Summary

Unicentric retrospective analysis of a cohort of 602 young adult and adolescent patients, aged 15 to 30 years, with haematological malignancies, and managed between 2000 and 2016

Detailed Description

The therapeutic results (response and survival) of young adult and adolescent patients with hematological malignancies are generally lower than those usually observed in adults over the age of 30, wit...

Eligibility Criteria

Inclusion

  • Malignant hemopathies (acute leukemia, non-Hodgkin's lymphoma, Hodgkin's lymphoma) in primary care between 2000 and 2016.

Exclusion

  • Not applicable

Key Trial Info

Start Date :

January 1 2000

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

December 31 2016

Estimated Enrollment :

602 Patients enrolled

Trial Details

Trial ID

NCT03469921

Start Date

January 1 2000

End Date

December 31 2016

Last Update

March 19 2018

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Institut Paoli Calmettes

Marseille, Bouches Du Rhone, France, 13009

Unicentric Retrospective Analysis of a Cohort of 602 Young Adult and Adolescent Patients (AJA), Aged 15 to 30 Years, With Haematological Malignancies, and Managed Between 2000 and 2016 | DecenTrialz